Precirix NV
Overview
Precirix NV is a private biotechnology company based in Belgium, focused on developing innovative radiopharmaceuticals for the treatment of cancer. The company leverages advanced technology to target and treat a range of oncological indications, aiming to improve patient outcomes.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Precirix NV in our records. PharmaTek screens the full directory against live FDA enforcement data.
Related companies
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.